1 Dr. Cook is Chief Translational Innovation Officer for the Semel Institute for Neuroscience and Human Behavior, and is a professor with the Department of Psychiatry and Biobehavioral Sciences of the David Geffen School of Medicine, and the Department of Bioengineering of the Henry Samueli School of Engineering and Applied Science at the University of California, Los Angeles. He is also with the Veterans Affairs Greater Los Angeles Healthcare System.
2 Dr. Cook reports that his active biomedical device patents are assigned to the University of California. In the past year, he has advised Arctica Health, Cerêve, and NeuroDetect, and UCLA has received research grant funding from NeoSync, Inc., for his work. He has been granted stock options in NeuroSigma, the licensee of some of his inventions, and he currently is on leave as its chief medical officer and senior vice president.